Four-year survival update for metastatic melanoma (MM) patients (pts) treated with ipilimumab (IPI) + dacarbazine (DTIC) on phase 3 study CA184-024 Meeting Abstract
| Authors: | Maio, M.; Bondarenko, I.; Robert, C.; Thomas, L.; Garbe, C.; Testori, A.; Francis, S.; Chin, K.; Wolchok, J. |
| Abstract Title: | Four-year survival update for metastatic melanoma (MM) patients (pts) treated with ipilimumab (IPI) + dacarbazine (DTIC) on phase 3 study CA184-024 |
| Meeting Title: | 37th Congress of the European Society for Medical Oncology (ESMO) |
| Journal Title: | Annals of Oncology |
| Volume: | 23 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2012 Sep 28-Oct 2 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2012-09-01 |
| Start Page: | ix367 |
| Language: | English |
| ACCESSION: | WOS:000309409002065 |
| PROVIDER: | wos |
| PUBMED: | 23012731 |
| DOI: | 10.1093/annonc/mds409 |
| Notes: | Meeting Abstract: 1127P -- "Source: Wos" |
